Cyproheptadine in treatment of chronic schizophrenia:a double‐blind, placebo‐controlled study-Reference-Cited by-同舟云学术

Cyproheptadine in treatment of chronic schizophrenia:a double‐blind, placebo‐controlled study

Published:1999-02 Issue:1 Volume:24 Page:49-52
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:Journal of Clinical Pharmacy and Therapeutics

Author:

Akhondzadeh S.¹,Mohammadi M. R.¹,Amini‐Nooshabadi H.¹,Davari‐Ashtiani R.¹

Affiliation:

1. Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, South Kargar Avenue, Tehran 13334, Iran

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2710.1999.00197.x

Reference22 articles.

1. Schizophrenia: manifestation, incidence and course in different cultures. A World Health Organization ten‐country study;Jablensky A;Psychological Medicine,1991

2. Negative v Positive Schizophrenia

3. The Distinction of Positive and Negative Symptoms

4. Functional interaction between serotonin S2 and dopamine D2 neurotransmission as revealed by selective antagonism of hyperactivity to tryptamine and apomorphine;Awouters FHL;Journal of Pharmaceutical and Experimental Therapeutics,1990

5. Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. L-Theanine adjunct to risperidone in the treatment of chronic schizophrenia inpatients: a randomized, double-blind, placebo-controlled clinical trial;Psychopharmacology;2023-09-12

2. A Consideration for the Study of the Use of Cyproheptadine in Parkinson Disease Psychosis;Journal of Clinical Psychopharmacology;2023-08-04

3. Cyproheptadine: a psychopharmacological treasure trove?;CNS Spectrums;2021-02-26

4. The past and future of novel, non-dopamine-2 receptor therapeutics for schizophrenia: A critical and comprehensive review;Journal of Psychiatric Research;2019-01

5. Role of Cyproheptadine in Various Psychiatric Conditions;Indian Journal of Private Psychiatry;2019